Derek Jantz - Jun 7, 2022 Form 4 Insider Report for PRECISION BIOSCIENCES INC (DTIL)

Role
Chief Scientific Officer, Director
Signature
/s/ John Alexander Kelly, Attorney-in-Fact for Derek Jantz
Stock symbol
DTIL
Transactions as of
Jun 7, 2022
Transactions value $
-$38,829
Form type
4
Date filed
6/9/2022, 04:42 PM
Previous filing
Mar 7, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DTIL Common Stock Options Exercise +29.5K +0.73% 4.06M Jun 7, 2022 Direct F1, F2
transaction DTIL Common Stock Options Exercise +12.2K +0.3% 4.07M Jun 7, 2022 Direct F1, F2
transaction DTIL Common Stock Sale -$38.8K -18.8K -0.46% $2.06 4.06M Jun 8, 2022 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DTIL Restricted Stock Units Options Exercise $0 -29.5K -50% $0.00 29.5K Jun 7, 2022 Common Stock 29.5K Direct F2, F4
transaction DTIL Restricted Stock Units Options Exercise $0 -12.2K -33.34% $0.00 24.4K Jun 7, 2022 Common Stock 12.2K Direct F2, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the partial vesting and settlement of Restricted Stock Units ("RSUs") on June 7, 2022.
F2 Each RSU represents a contingent right to receive one share of the Company's Common Stock.
F3 The sales were effected pursuant to a Rule 10b5-1 plan. The transaction was a sell-to-cover exercise, with shares sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs.
F4 On June 7, 2021 the Reporting person was granted RSUs, which vest in two equal annual installments beginning on June 7, 2022, subject to the Reporting Person's continued service to the Company through the applicable vesting dates.
F5 On June 7, 2021 the Reporting person was granted RSUs, which vest in three substantially equal annual installments beginning on June 7, 2022, subject to the Reporting Person's continued service to the Company through the applicable vesting dates.